Ameriprise Financial Inc. bought a new stake in Transcat, Inc. (NASDAQ:TRNS) during the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm bought 182,000 shares of the scientific and technical instruments company’s stock, valued at approximately $2,484,000. Ameriprise Financial Inc. owned approximately 2.55% of Transcat at the end of the most recent reporting period.
A number of other institutional investors also recently modified their holdings of TRNS. Northern Trust Corp lifted its holdings in shares of Transcat by 9.5% during the second quarter. Northern Trust Corp now owns 18,062 shares of the scientific and technical instruments company’s stock worth $220,000 after purchasing an additional 1,570 shares during the period. QCI Asset Management Inc. NY lifted its holdings in shares of Transcat by 31.1% during the third quarter. QCI Asset Management Inc. NY now owns 32,234 shares of the scientific and technical instruments company’s stock worth $437,000 after purchasing an additional 7,647 shares during the period. Quantum Capital Management acquired a new position in Transcat in the third quarter valued at $696,000. Vanguard Group Inc. lifted its holdings in Transcat by 3.4% in the second quarter. Vanguard Group Inc. now owns 133,579 shares of the scientific and technical instruments company’s stock valued at $1,623,000 after buying an additional 4,450 shares during the period. Finally, Neuberger Berman Group LLC lifted its holdings in Transcat by 3.1% in the second quarter. Neuberger Berman Group LLC now owns 164,993 shares of the scientific and technical instruments company’s stock valued at $2,005,000 after buying an additional 4,900 shares during the period. Hedge funds and other institutional investors own 56.69% of the company’s stock.
Several research firms recently issued reports on TRNS. Zacks Investment Research upgraded shares of Transcat from a “sell” rating to a “hold” rating in a report on Tuesday, January 2nd. Singular Research began coverage on shares of Transcat in a research note on Wednesday, November 15th. They issued a “buy” rating and a $15.30 price target for the company.
Transcat, Inc. (NASDAQ TRNS) traded down $0.15 during trading hours on Friday, hitting $13.85. 2,829 shares of the stock traded hands, compared to its average volume of 19,642. Transcat, Inc. has a one year low of $10.50 and a one year high of $15.15. The company has a market capitalization of $100.38, a P/E ratio of 23.03, a PEG ratio of 3.38 and a beta of 0.45. The company has a current ratio of 2.24, a quick ratio of 1.53 and a debt-to-equity ratio of 0.61.
WARNING: “182,000 Shares in Transcat, Inc. (TRNS) Purchased by Ameriprise Financial Inc.” was first posted by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are viewing this report on another domain, it was illegally copied and reposted in violation of U.S. & international copyright & trademark legislation. The correct version of this report can be read at https://www.dispatchtribunal.com/2018/01/13/ameriprise-financial-inc-acquires-new-stake-in-transcat-inc-trns.html.
Transcat, Inc is a provider of calibration and laboratory instrument services and a distributor of professional grade test, measurement and control instrumentation. The Company conducts its business through two segments: service (Service) and distribution (Distribution). Through the Service segment, the Company offers calibration, repair, inspection, analytical qualifications, preventative maintenance and other related services, a majority of which are processed through its asset management system, CalTrak (CalTrak).
Receive News & Ratings for Transcat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Transcat and related companies with MarketBeat.com's FREE daily email newsletter.